Policy & Regulation

WHO panel advises on governance of genome editing

Read more

A new paradigm for gene therapy

Read more

Addressing the challenges of gene therapy medicinal products

Read more

EU medicine approvals with public health impact

Read more

Drug development robust, despite the pandemic

Read more

Real world evidence is changing regulatory policy

Read more

Integrated product development for ATMPs

Read more

Establishing a new role for real world evidence

Read more

Improving cardiac safety testing protocols

Read more

What patients really want: involvement

Read more